Avalo Therapeutics, Inc.: Form 8-K, filed Sep 9, 2024
Filed with the SEC on Sep 9, 2024 and accepted by EDGAR at Sep 9, 2024, 07:22 ET.
Items reported
- Item 8.01 Other events
- Item 9.01 Financial statements and exhibits
Sections
Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. The main document on sec.gov.
Source: SEC EDGAR, the filing index for accession 0001628280-24-039764. Last ingested by Listed: Oct 29, 2026, 16:18 ET. Listed shows no prices and gives no investment advice.